Dmitry Balyasny’s Apellis Pharmaceuticals APLS Stock Holding History

Dmitry Balyasny’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-120,000	Closed	-$3.01M	–	2863
2025 Q4	$3.01M	Buy	+120,000	New	+$2.82M	﹤0.01%	1664

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Dmitry Balyasny's APLS Position: Q2 2026 in Review

Dmitry Balyasny sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1,917,501 shares — an estimated $77.1M sold.

Dmitry Balyasny first reported a position in APLS in Q2 2018 and held it in 14 quarters. The position peaked at $77.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Dmitry Balyasny reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 1,917,501 Apellis Pharmaceuticals shares in Q2 2026, an estimated $77.1M.
Dmitry Balyasny first reported a position in Apellis Pharmaceuticals in Q2 2018 and held it in 14 quarters.
Dmitry Balyasny's Apellis Pharmaceuticals position peaked at $77.1M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.